HsinLiang Lee - Ainos Chief Officer
| AIMD Stock | USD 0.63 0.02 3.08% |
Executive
HsinLiang Lee is Chief Officer of Ainos Inc
| Age | 54 |
| Phone | 858 869 2986 |
| Web | https://www.ainos.com |
HsinLiang Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of HsinLiang Lee against Ainos stock is an integral part of due diligence when investing in Ainos. HsinLiang Lee insider activity provides valuable insight into whether Ainos is net buyers or sellers over its current business cycle. Note, Ainos insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ainos'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
HsinLiang Lee over a year ago Acquisition by HsinLiang Lee of 8000 shares of SemiLEDS subject to Rule 16b-3 |
Ainos Management Efficiency
The company has return on total asset (ROA) of (0.2802) % which means that it has lost $0.2802 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.706) %, meaning that it created substantial loss on money invested by shareholders. Ainos' management efficiency ratios could be used to measure how well Ainos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andres Cedron | Orthofix Medical | 44 | |
| Craig Palmer | CVRx Inc | 47 | |
| Roberto Donadello | Orthofix Medical | N/A | |
| Jonelle Burnham | CVRx Inc | 54 | |
| Paul Pignato | CVRx Inc | N/A | |
| Jay Sturm | STRATA Skin Sciences | 69 | |
| Daniel JD | Orthopediatrics Corp | 55 | |
| Michael CPA | Anika Therapeutics | 51 | |
| Florian Tyrs | Artivion | N/A | |
| Ben Joseph | Anika Therapeutics | N/A | |
| Mark Namaroff | Anika Therapeutics | 62 | |
| Michael Soule | Movano Inc | N/A | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Leah Akin | Neuropace | N/A | |
| Tonya SPHR | CVRx Inc | 53 | |
| Irina Ridley | Neuropace | 38 | |
| Michael Levitz | Anika Therapeutics | 50 | |
| Dylan John | Neuropace | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| MSc MD | CVRx Inc | N/A | |
| Joel Batts | Orthopediatrics Corp | N/A | |
Management Performance
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 |
Ainos Inc Leadership Team
Elected by the shareholders, the Ainos' board of directors comprises two types of representatives: Ainos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ainos. The board's role is to monitor Ainos' management team and ensure that shareholders' interests are well served. Ainos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ainos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| HuiLan Wu, Chief Officer | ||
| HsinLiang Lee, Chief Officer | ||
| Lawrence Lin, Executive Operations | ||
| ChihHeng Lu, Director Developoment | ||
| ChunHsien Tsai, President Board | ||
| MengLin Sung, Chief Officer | ||
| John Esq, Corp Counsel |
Ainos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ainos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 | ||||
| Operating Margin | (359.85) % | ||||
| Current Valuation | 16.53 M | ||||
| Shares Outstanding | 13.84 M | ||||
| Shares Owned By Insiders | 65.50 % | ||||
| Shares Owned By Institutions | 1.10 % | ||||
| Number Of Shares Shorted | 177.14 K | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 231.65 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ainos Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ainos. If investors know Ainos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ainos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ainos Inc is measured differently than its book value, which is the value of Ainos that is recorded on the company's balance sheet. Investors also form their own opinion of Ainos' value that differs from its market value or its book value, called intrinsic value, which is Ainos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ainos' market value can be influenced by many factors that don't directly affect Ainos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ainos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ainos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ainos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.